+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

T-Cell Immunotherapy Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 121 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5624402
UP TO OFF until Dec 31st 2022
The Global T-Cell Immunotherapy Market is projected to reach USD 9,684.58 million by 2027 from USD 4,712.10 million in 2021, at a CAGR 12.75% during the forecast period.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas T-Cell Immunotherapy Market size was estimated at USD 1,633.21 million in 2021, is expected to reach USD 1,848.63 million in 2022, and is projected to grow at a CAGR of 12.92% to reach USD 3,386.23 million by 2027.
  • The Asia-Pacific T-Cell Immunotherapy Market size was estimated at USD 1,076.95 million in 2021, is expected to reach USD 1,237.07 million in 2022, and is projected to grow at a CAGR of 13.46% to reach USD 2,297.78 million by 2027.
  • The Europe, Middle East & Africa T-Cell Immunotherapy Market size was estimated at USD 2,001.93 million in 2021, is expected to reach USD 2,224.18 million in 2022, and is projected to grow at a CAGR of 12.23% to reach USD 4,000.57 million by 2027.

Market Segmentation & Coverage:


The report on t-cell immunotherapy identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the t-cell immunotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:

Mechanism Of Action:

  • Active Immunotherapy
  • Passive Immunotherapy

Product Class:

  • Bispecific Antibodies
  • Cytokines
  • Monoclonal Antibodies
  • Oncolytic Virus Therapy

Type of Therapy:

  • CAR-T
  • TCR
  • TIL

Indication:

  • B-cell Malignancies
  • Liver Cancer
  • Prostate Cancer
  • Renal Cell Carcinoma

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Adaptimmune Therapeutics PLC
  • Apac Biotech
  • Atara Biotherapeutics, Inc.
  • Autolus Limited
  • bluebird bio, Inc.
  • Bristol-Myers Squibb Company
  • CARsgen Therapeutics, Ltd
  • Cellectis SA
  • Chimera Bioengineering
  • Dendreon Pharmaceuticals LLC
  • Eureka Therapeutics, Inc.
  • Gilead Sciences, Inc.
  • Green Cross Corporation
  • Innovative Cellular Therapeutics
  • Iovance Biotherapeutics, Inc.
  • JW CreaGene Co., Ltd.
  • LAVA Therapeutics BV
  • Lyell Immunopharma
  • Neogene Therapeutics
  • NeoTX Therapeutics
  • Novartis AG
  • Oxford Vacmedix
  • Poseida Therapeutics
  • TScan Therapeutics, Inc.
  • Xenetic Biosciences
  • ZIOPHARM Oncology
Frequently Asked Questions about the T-Cell Immunotherapy Market

What is the estimated value of the T-Cell Immunotherapy Market?

The T-Cell Immunotherapy Market was estimated to be valued at $4712.1 Million in 2021.

What is the growth rate of the T-Cell Immunotherapy Market?

The growth rate of the T-Cell Immunotherapy Market is 12.7%, with an estimated value of $9684.58 Million by 2027.

What is the forecasted size of the T-Cell Immunotherapy Market?

The T-Cell Immunotherapy Market is estimated to be worth $9684.58 Million by 2027.

Who are the key companies in the T-Cell Immunotherapy Market?

Key companies in the T-Cell Immunotherapy Market include Adaptimmune Therapeutics PLC, Apac Biotech, Atara Biotherapeutics, Inc., Autolus Limited, bluebird bio, Inc., Bristol, Myers Squibb Company, CARsgen Therapeutics, Ltd and Chimera Bioengineering.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Americas T-Cell Immunotherapy Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States
5. Asia-Pacific T-Cell Immunotherapy Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
6. Europe, Middle East & Africa T-Cell Immunotherapy Market
6.1. Introduction
6.2. France
6.3. Germany
6.4. Italy
6.5. Netherlands
6.6. Qatar
6.7. Russia
6.8. Saudi Arabia
6.9. South Africa
6.10. Spain
6.11. United Arab Emirates
6.12. United Kingdom
7. Company Usability Profiles
7.1. Adaptimmune Therapeutics PLC
7.2. Apac Biotech
7.3. Atara Biotherapeutics, Inc.
7.4. Autolus Limited
7.5. bluebird bio, Inc.
7.6. Bristol-Myers Squibb Company
7.7. CARsgen Therapeutics, Ltd
7.8. Cellectis SA
7.9. Chimera Bioengineering
7.10. Dendreon Pharmaceuticals LLC
7.11. Eureka Therapeutics, Inc.
7.12. Gilead Sciences, Inc.
7.13. Green Cross Corporation
7.14. Innovative Cellular Therapeutics
7.15. Iovance Biotherapeutics, Inc.
7.16. JW CreaGene Co., Ltd.
7.17. LAVA Therapeutics BV
7.18. Lyell Immunopharma
7.19. Neogene Therapeutics
7.20. NeoTX Therapeutics
7.21. Novartis AG
7.22. Oxford Vacmedix
7.23. Poseida Therapeutics
7.24. TScan Therapeutics, Inc.
7.25. Xenetic Biosciences
7.26. ZIOPHARM Oncology
List of Figures
Figure 1. Global T-Cell Immunotherapy Market: Research Process
Figure 2. Global T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 3. Global T-Cell Immunotherapy Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global T-Cell Immunotherapy Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global T-Cell Immunotherapy Market Size, by Region, 2027
Figure 6. Americas T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 7. Americas T-Cell Immunotherapy Market Size, by Country, 2021 Vs 2027 (%)
Figure 8. Americas T-Cell Immunotherapy Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 9. Competitive Strategic Window For Americas T-Cell Immunotherapy Market Size, by Country, 2027
Figure 10. Argentina T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 11. Brazil T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 12. Canada T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 13. Mexico T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 14. United States T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 15. United States T-Cell Immunotherapy Market Size, by State, 2021 Vs 2027 (%)
Figure 16. United States T-Cell Immunotherapy Market Size, by State, 2021 Vs 2027 (USD Million)
Figure 17. Competitive Strategic Window For United States T-Cell Immunotherapy Market Size, by State, 2027
Figure 18. Asia-Pacific T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 19. Asia-Pacific T-Cell Immunotherapy Market Size, by Country, 2021 Vs 2027 (%)
Figure 20. Asia-Pacific T-Cell Immunotherapy Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 21. Competitive Strategic Window For Asia-Pacific T-Cell Immunotherapy Market Size, by Country, 2027
Figure 22. Australia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 23. China T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 24. India T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 25. Indonesia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 26. Japan T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 27. Malaysia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 28. Philippines T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 29. Singapore T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 30. South Korea T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 31. Taiwan T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 32. Thailand T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 33. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 34. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Country, 2021 Vs 2027 (%)
Figure 35. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 36. Competitive Strategic Window For Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Country, 2027
Figure 37. France T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 38. Germany T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 39. Italy T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 40. Netherlands T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 41. Qatar T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 42. Russia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 43. Saudi Arabia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 44. South Africa T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 45. Spain T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 46. United Arab Emirates T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Figure 47. United Kingdom T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
List of Tables
Table 1. Global T-Cell Immunotherapy Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 4. Global T-Cell Immunotherapy Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 6. Global T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 7. Global T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 8. Global T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 9. Americas T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 10. Americas T-Cell Immunotherapy Market Size, by Country, 2019-2027 (USD Million)
Table 11. Americas T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 12. Americas T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 13. Americas T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 14. Americas T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 15. Argentina T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 16. Argentina T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 17. Argentina T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 18. Argentina T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 19. Argentina T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 20. Brazil T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 21. Brazil T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 22. Brazil T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 23. Brazil T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 24. Brazil T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 25. Canada T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 26. Canada T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 27. Canada T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 28. Canada T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 29. Canada T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 30. Mexico T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 31. Mexico T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 32. Mexico T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 33. Mexico T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 34. Mexico T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 35. United States T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 36. United States T-Cell Immunotherapy Market Size, by State, 2019-2027 (USD Million)
Table 37. United States T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 38. United States T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 39. United States T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 40. United States T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 41. Asia-Pacific T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 42. Asia-Pacific T-Cell Immunotherapy Market Size, by Country, 2019-2027 (USD Million)
Table 43. Asia-Pacific T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 44. Asia-Pacific T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 45. Asia-Pacific T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 46. Asia-Pacific T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 47. Australia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 48. Australia T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 49. Australia T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 50. Australia T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 51. Australia T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 52. China T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 53. China T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 54. China T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 55. China T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 56. China T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 57. India T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 58. India T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 59. India T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 60. India T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 61. India T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 62. Indonesia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 63. Indonesia T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 64. Indonesia T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 65. Indonesia T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 66. Indonesia T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 67. Japan T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 68. Japan T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 69. Japan T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 70. Japan T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 71. Japan T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 72. Malaysia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 73. Malaysia T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 74. Malaysia T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 75. Malaysia T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 76. Malaysia T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 77. Philippines T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 78. Philippines T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 79. Philippines T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 80. Philippines T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 81. Philippines T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 82. Singapore T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 83. Singapore T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 84. Singapore T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 85. Singapore T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 86. Singapore T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 87. South Korea T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 88. South Korea T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 89. South Korea T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 90. South Korea T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 91. South Korea T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 92. Taiwan T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 93. Taiwan T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 94. Taiwan T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 95. Taiwan T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 96. Taiwan T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 97. Thailand T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 98. Thailand T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 99. Thailand T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 100. Thailand T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 101. Thailand T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 102. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 103. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Country, 2019-2027 (USD Million)
Table 104. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 105. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 106. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 107. Europe, Middle East & Africa T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 108. France T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 109. France T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 110. France T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 111. France T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 112. France T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 113. Germany T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 114. Germany T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 115. Germany T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 116. Germany T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 117. Germany T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 118. Italy T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 119. Italy T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 120. Italy T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 121. Italy T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 122. Italy T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 123. Netherlands T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 124. Netherlands T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 125. Netherlands T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 126. Netherlands T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 127. Netherlands T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 128. Qatar T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 129. Qatar T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 130. Qatar T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 131. Qatar T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 132. Qatar T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 133. Russia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 134. Russia T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 135. Russia T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 136. Russia T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 137. Russia T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 138. Saudi Arabia T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 139. Saudi Arabia T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 140. Saudi Arabia T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 141. Saudi Arabia T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 142. Saudi Arabia T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 143. South Africa T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 144. South Africa T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 145. South Africa T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 146. South Africa T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 147. South Africa T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 148. Spain T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 149. Spain T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 150. Spain T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 151. Spain T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 152. Spain T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 153. United Arab Emirates T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 154. United Arab Emirates T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 155. United Arab Emirates T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 156. United Arab Emirates T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 157. United Arab Emirates T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)
Table 158. United Kingdom T-Cell Immunotherapy Market Size, 2019-2027 (USD Million)
Table 159. United Kingdom T-Cell Immunotherapy Market Size, by Mechanism Of Action, 2019-2027 (USD Million)
Table 160. United Kingdom T-Cell Immunotherapy Market Size, by Product Class, 2019-2027 (USD Million)
Table 161. United Kingdom T-Cell Immunotherapy Market Size, by Type Of Therapy, 2019-2027 (USD Million)
Table 162. United Kingdom T-Cell Immunotherapy Market Size, by Indication, 2019-2027 (USD Million)

Companies Mentioned

  • Adaptimmune Therapeutics PLC
  • Apac Biotech
  • Atara Biotherapeutics, Inc.
  • Autolus Limited
  • bluebird bio, Inc.
  • Bristol-Myers Squibb Company
  • CARsgen Therapeutics, Ltd
  • Cellectis SA
  • Chimera Bioengineering
  • Dendreon Pharmaceuticals LLC
  • Eureka Therapeutics, Inc.
  • Gilead Sciences, Inc.
  • Green Cross Corporation
  • Innovative Cellular Therapeutics
  • Iovance Biotherapeutics, Inc.
  • JW CreaGene Co., Ltd.
  • LAVA Therapeutics BV
  • Lyell Immunopharma
  • Neogene Therapeutics
  • NeoTX Therapeutics
  • Novartis AG
  • Oxford Vacmedix
  • Poseida Therapeutics
  • TScan Therapeutics, Inc.
  • Xenetic Biosciences
  • ZIOPHARM Oncology

Methodology

Loading
LOADING...